SYNTHESIS
July 1998
1037
in anhyd DMF (2 mL) according to the general procedure A (reaction
time: 8 h). After column chromatographic separation, the crystalline
5R-product 2c and the syrupy 5S-product 3c were isolated (Table 2).
2c:
(5R)-1,2-O-Isopropylidene-5-C-perfluorobutyl-α-D-xylofuranose
(6a): Compound 2a (0.83 g, 1.66 mmol) was debenzylated according
to the general procedure C (reaction time: 96 h). The residue was
crystallized from hexane/EtOAc (colourless needles) (Table 2).
1H NMR (250 MHz, acetone-d6): δ = 1.29, 1.43 (s, 3 H, CH3), 4.32
(m, 1 H, H-3), 4.39 (m, 1 H, H-4), 4.57 (d, 1 H, J1,2 = 3.5 Hz, H-2),
4.70 (dddd, 1 H, J5,F = 22.7 Hz, J5,F’ = 3.5 Hz, J5,OH = 1.8 Hz, H-5), ≈
4.9 (br, 2 H, OH), 5.95 (d, 1 H, J1,2 = 3.5 Hz, H-1).
1H NMR (250 MHz, CDCl3): δ = 1.25, 1.41 (s, 3 H, CH3), ≈ 3.16 (br,
1 H, OH), 4.00 (m, 1 H, H-3), 4.40 (m, 1 H, H-4), 4.42 (d, 1 H, J =
11.6 Hz, CH2Ph), 4.47 (m, 1 H, H-5), 4.56 (d, 1 H, J1,2 = 3.7 Hz, H-
2), 4.61 (d, 1 H, J = 11.6 Hz, CH2Ph), 5.91 (d, 1 H, J1,2 = 3.7 Hz, H-
1), 7.18–7.30 (m, 5 H, C6H5).
13C NMR (62 MHz, acetone-d6): δ = 26.6, 27.3 (CH3), 68.5 (dd, JC-5,F
= 20.8 Hz, JC-5,F´ = 28.6 Hz, C-5), 76.5 (d, JC-3,F = 3.7 Hz, C-3), 77.5
(C-4), 86.6 (C-2), 105.6 (C-1), 112.5 [C(CH3)2], 110–122 (m, 3 CF2,
CF3).
13C NMR (62 MHz, CDCl3) : δ = 26.3, 26.8 (CH3), 67.6 (dd, JC-5,F
=
21.5 Hz, JC-5,F’ = 28.7 Hz, C-5), 72.4 (CH2Ph), 75.8 (C-4), 82.1 (C-2),
83.2 (C-3), 104.9 (C-1), 112.6 [C(CH3)2], 105 –120 (m, 7 CF2, CF3),
128.2, 128.7, 129.0, 136.5 (C6H5).
19F NMR (235 MHz, acetone-d6): δ= –128.2 to –124.4 (m, 3 F, CF2),
–123.1, –122.7 (s, 1 F, CF2), –119.7 to –118.5 (m, 1 F, CF2CH2),
–81.6 (CF3).
19F NMR (235 MHz, CDCl3): δ = –126.2 to –125.0 (m, 3 F, CF2),
–122.5 to –121.7 (m, 10 F, CF2), –120.1 to – 118.9 (m, 1 F, CF2CH2),
–80.7 (CF3).
MS (CI-isobutane): m/z = 699 (M+ + H).
(5R)-1,2-O-Isopropylidene-5-C-perfluorohexyl-α-D-xylofuranose
(6b): Compound 2b (1.64 g, 2.74 mmol) was debenzylated according
to the general procedure C (reaction time: 70 h). The residue was
crystallized from hexane/EtOAc (Table 2).
3c:
1H NMR (250 MHz, CDCl3): δ = 1.26, 1.42 (s, 3 H, CH3), 4.20 (m, 3
H, H-3, H-5, OH), 4.31 (m, 1 H, H-4), 4.49 (d, 1 H, J = 11.0 Hz,
CH2Ph), 4.56 (d, 1 H, J1,2 = 3.7 Hz, H-2), 4.60 (d, 1 H, J = 11.0 Hz,
CH2Ph), 5.95 (d, 1 H, J1,2 = 3.7 Hz, H-1), 7.20–7.31 (m, 5 H, C6H5).
1H NMR (250 MHz, acetone-d6): δ = 1.29, 1.43 (s, 3 H, CH3), 4.32
(m, 1 H, H-3), 4.39 (m, 1 H, H-4), 4.57 (d, 1 H, J1,2 = 3.8 Hz, H-2),
4.63–4.79 (m, 1 H, H-5), ≈ 4.86 (br, 1 H, OH), ≈ 4.98 (br, 1 H, OH),
5.95 (d, 1 H, J1,2 = 3.8 Hz, H-1).
13C NMR (62 MHz, CDCl3) : δ = 26.1, 26.6 (CH3), 69.9 (dd, JC-5,F
=
22.5 Hz, JC-5,F’ = 25.8 Hz, C-5), 72.8 (CH2Ph), 74.8 (C-4), 81.8 (C-2),
84.7 (C-3), 104.6 (C-1), 112.1 [C(CH3)2], 105 –120 (m, 7 CF2, CF3),
128.2, 128.7, 128.8, 135.8 (C6H5).
13C NMR (62 MHz, acetone-d6): δ = 26.6, 27.3 (CH3), 68.6 (dd, JC-5,F
=
21.6 Hz, JC-5,F’ = 28.1 Hz, C-5), 76.6 (d, JC-3,F = 4.0 Hz, C-3), 77.6 (C-4),
86.6 (C-2), 105.7 (C-1), 112.5 [C(CH3)2], 105–122 (m, 5 CF2, CF3).
19F NMR (235 MHz, acetone-d6): δ = –127.9 to –125.1 (m, 3 F, CF2),
–123.1, –122.8, –122.5 (s, 1 F, CF2), –122.0 (s, 3 F, CF2), –119.6 to
–118.4 (m, 1 F, CF2CH2), –81.4 (CF3).
19F NMR (235 MHz, CDCl3): δ = –127.8 to –124.8 (m, 3 F, CF2),
–123.6 to –121.6 (m, 10 F, CF2), –117.9 to –116.7 (m, 1 F, CF2CH2),
–81.3 (CF3).
(5R)-5-O-Acetyl-3-O-benzyl-1,2-O-isopropylidene-5-C-perfluorooc-
tyl-α-D-xylofuranose (4c): Compound 2c (0.43 g, 0.62 mmol) was
acetylated with Ac2O/pyridine as described in the general procedure
B. After column chromatographic separation (Rf = 0.55, eluent: hep-
tane/EtOAc, 5 : 1), the crystalline product 4c was isolated (Table 2).
1H NMR (250 MHz, CDCl3): δ = 1.31, 1.50 (s, 3 H, CH3), 2.04 (s, 3
H, COCH3), 4.03 (dd, 1 H, J3,4 = 3.7 Hz, J4,5 = 3.1 Hz, H-4), 4.48 (d,
1 H, J = 11.3 Hz, CH2Ph), 4.51 (dd, 1 H, J2,3 = 8.5 Hz, H-3), 4.62 (d,
1 H, J = 11.3 Hz, CH2Ph), 4.62 (dd, 1 H, J1,2 = 4.0 Hz, H-2), 5.90 (d,
1 H, J1,2 = 4.0 Hz, H-1), 6.15 (ddd, 1 H, J5,F = 20.0 Hz, J5,F’ = 8.4 Hz,
H-5), 7.26–7.39 (m, 5 H, C6H5).
(5R)-1,2-O-Isopropylidene-5-C-perfluorooctyl-α-D-xylofuranose
(6c): Compound 2c (0.78 g, 1.11 mmol) was debenzylated according
to the general procedure C (reaction time: 84 h). The residue was
crystallized from hexane/EtOAc (Table 2).
1H NMR (250 MHz, acetone-d6): δ = 1.29, 1.43 (s, 3 H, CH3), 4.33
(m, 1 H, H-3), 4.39 (m, 1 H, H-4), 4.57 (d, 1 H, J1,2 = 3.7 Hz, H-2),
4.62–4.78 (m, 1 H, H-5), ≈ 4.84 (br, 1 H, OH), ≈ 4.97 (br, 1 H, OH),
5.95 (d, 1 H, J1,2 = 3.7 Hz, H-1).
13C NMR (62 MHz, acetone-d6): δ = 26.6, 27.3 (CH3), 68.6 (dd, JC-5,F
= 21.7 Hz, JC-5,F’ = 28.1 Hz, C-5), 76.6 (d, JC-3,F = 4.0 Hz, C-3), 77.6
(C-4), 86.6 (C-2), 105.7 (C-1), 112.5 [C(CH3)2], 105–122 (m, 7 CF2,
CF3).
13C NMR (62 MHz, CDCl3) : δ = 20.6 (COCH3), 26.6, 27.1
[C(CH3)2], 66.0 (dd, JC-5,F = 20.9 Hz, JC-5,F’ = 30.3 Hz, C-5), 72.6
(CH2Ph), 76.1 (C-3), 82.6 (C-4), 82.7 (C-2), 104.8 (C-1), 112.5
[C(CH3)2], 105–120 (m, 7 CF2, CF3), 128.3, 128.4, 128.8, 137.0
(C6H5), 168.7 (COCH3).
19F NMR (235 MHz, acetone-d6): δ = –126.4 to –125.0 (m, 3 F, CF2),
–122.9 (s, 1 F, CF2), –122.1 to –121.9 (m, 9 F, CF2), –119.5 to –118.4
(m, 1 F, CF2CH2), –81.4 (CF3).
19F NMR (235 MHz, CDCl3): δ = –125.8 (s, 2 F, CF2CF3), –123.6 to
–119.9 (m, 11 F, CF2), –118.6 to –117.0 (m, 1 F, CF2CH2), –80.6 (CF3).
(5R)-5-C-Perfluorobutyl-D-xylose (7a): Compound 6a (0.36 g, 0.89
mmol) was deacetylated according to the general procedure D (reac-
tion time: 6 h). The residue was recrystallized from heptane/acetone
(Table 2).
(5S)-5-O-Acetyl-3-O-benzyl-1,2-O-isopropylidene-5-C-perfluorooc-
tyl-α-D-xylofuranose (5c): Compound 3c (0.40 g, 0.57 mmol) was
acetylated with Ac2O/pyridine as described in the general procedure
B. After column chromatographic separation (Rf = 0.69, eluent: hep-
tane/EtOAc, 5 : 1), the crystalline product 5c was isolated (Table 2).
1H NMR (250 MHz, CDCl3): δ = 1.31, 1.49 (s, 3 H, CH3), 1.95 (s, 3
H, COCH3), 3.98 (d, 1 H, J3,4 = 3.0 Hz, H-3), 4.46 (d, 1 H, J =
11.3 Hz, CH2Ph), 4.53 (dd, 1 H, J4,5 = 12.2 Hz, H-4), 4.54 (d, 1 H, J
= 11.3 Hz, CH2Ph), 4.54 (d, 1 H, J1,2 = 3.6 Hz, H-2), 5.87 (m, 1 H, H-
5), 5.94 (d, 1 H, J1,2 = 3.6 Hz, H-1), 7.26 –7.39 (m, 5 H, C6H5).
13C NMR (62 MHz, CDCl3) : δ = 20.1 (COCH3), 26.3, 26.8
[C(CH3)2], 66.7 (dd, JC-5,F = 23.7 Hz, JC-5,F’ = 27.3 Hz, C-5), 72.1
(CH2Ph), 75.9 (C-4), 80.5 (C-3), 81.6 (C-2), 105.8 (C-1), 112.3
[C(CH3)2], 105–120 (m, 7 CF2, CF3), 128.2, 128.6, 128.7, 136.6
(C6H5), 167.3 (COCH3).
19F NMR (235 MHz, CDCl3): δ = –127.1 to –118.0 (m, 3 CF2), –81.6
(CF3) (see also Table 3).
(5R)-5-C-Perfluorohexyl-D-xylose (7b): Compound 6b (1.14 g, 2.24
mmol) was deacetylated according to the general procedure D (reac-
tion time: 20 h). The residue was recrystallized from heptane/acetone
(Table 2).
19F NMR (235 MHz, CDCl3, CFCl3): δ = –126.6 to –118.0 (m, 5 CF2),
–81.4 (CF3) (see also Table 3).
(5R)-5-C-Perfluorooctyl-D-xylose (7c): Compound 6c (0.25 g,
0.4 mmol) was deacetylated according to the general procedure D (re-
action time: 20 h). The residue was recrystallized from heptane/ace-
tone (Table 2).
19F NMR (235 MHz, CDCl3): δ = –125.9 (s, 2 F, CF2CF3), –122.5 (s,
2 F, CF2), –121.4 (m, 10 F, CF2), –120.2 to –116.3 (m, 2 F, CF2CH2),
–80.6 (CF3).
19F NMR (235 MHz, CDCl3, CFCl3): δ = –126.7 to –116.6 (m, 7 CF2),
–81.4 (CF3) (see also Table 3).